Journal decision profile

Radiotherapy and Oncology

Medicine · Physics and Astronomy

Radiotherapy and Oncology's 2026 Journal Metrics Score is 0.7, ranking Q4 in Radiation and 2 other subfields. Two-year citation average from OpenAlex data, updated August 2026.

Elsevier BVNetherlandspISSN 0167-8140eISSN 1879-0887
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
0.7

Journal Metrics Score 2026 · 2021–2024 window citedness 0.73.

Review & acceptance time
i
Review & acceptance timeCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
103 daysmedian

Middle 50%: 70–146 days

100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025

Radiotherapy and Oncology accepts papers a median of 103 days after submission, including peer review and revisions. That is faster than 68% of comparable journals with PubMed timing data.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$3,210

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit Radiotherapy and Oncology?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
0.72026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#3 / 1,049LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
4.5%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
0.00MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
103 daysIQR 70–146 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
3027 / yr2021–2024 AVG
Field-normalized top 10% share4.5%

545 of 12,108 works · same type, year & subfield

Field-normalized top 1% share0.4%

53 works · same type, year & subfield

Median FWCI0.00×

Below field-year expectation

Source output rank#3

of 1,049 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.00, so its typical recent paper runs about 100% below its field benchmark.

What does Top 10% Share mean?

4.5% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

30052016
24062017
28112018
32172019
27562020
28352021
24322022
30732023
37682024
34692025

Recent work-type mix

12,108 OpenAlex works · 2021–2024

Conference abstract51.1%
Article46.4%
Paratext1%
Review0.9%
Letter0.4%
Erratum0.1%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Radiotherapy and Oncology publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Advanced Radiotherapy Techniques1826
Radiomics and Machine Learning in Medical Imaging748
Head and Neck Cancer Studies569
Advances in Oncology and Radiotherapy482
Radiation Therapy and Dosimetry443
Medical Imaging Techniques and Applications378
Prostate Cancer Diagnosis and Treatment348
Lung Cancer Diagnosis and Treatment310
Breast Cancer Treatment Studies292
Endometrial and Cervical Cancer Treatments259
Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 12,108 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
RadiationQ4
Radiology, Nuclear Medicine and ImagingQ4
Pulmonary and Respiratory MedicineQ4

Is Radiotherapy and Oncology a good journal?

A lower-cited Q4 journal by citation data

By citation data, Radiotherapy and Oncology is in the lowest quartile in Radiation and 2 other subfields and ranks #791 of 897 Oncology journals by Journal Metrics Score (top 89%). A Q4 placement means its papers are cited less than most in the subfield; on its own it does not mean the journal is predatory or that its peer review is weak. Radiotherapy and Oncology's 2026 Journal Metrics Score is 0.7. Recent papers took a median of 103 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $3,210 USD. OpenAlex classifies its papers in subfields including Radiation, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine, so check that your topic fits its scope.

Best quartile
Q4
Radiation
Rank in Oncology
#791 of 897
Top 89%
2026 Journal Metrics Score
0.7
Acceptance rate
Not published
By the journal or publisher
Submission to acceptance
103 days
Median, PubMed records
Indicative APC
$3,210
OpenAlex, verify with the journal
Papers published in 2025
3,469
OpenAlex works

Check before you submit

  • Confirm the current article processing charge, waivers, and any institutional agreement on the journal website; the OpenAlex figure is indicative.
  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q4
Subfield Quartile
B1
CAS Block

Ranking and source check

#791
of 897 Oncology field journals
#25
among Q4 Oncology journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
57,857
H-Index
226
Fully Open Access
No
Recent OA Works
12,521
Subject Areas
RadiationRadiology, Nuclear Medicine and ImagingPulmonary and Respiratory Medicine

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to Radiotherapy and Oncology

  1. 1

    Check the scope

    OpenAlex classifies Radiotherapy and Oncology's papers in subfields including Radiation, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    Radiotherapy and Oncology homepage ↗
  3. 3

    Submit through Editorial Manager

    Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage.

  4. 4

    Plan for costs

    OpenAlex lists an indicative article processing charge of $3,210 USD. Check the current fee, waivers, and any institutional agreement on the journal website.

  5. 5

    Know what to expect

    Recent accepted papers took a median of 103 days from submission to acceptance, including revisions (PubMed dates). Radiotherapy and Oncology does not publish an acceptance rate.

Submission system from the publisher's author information, checked 2026-10-27. Individual journals can differ, so follow the link in the journal's own author guidelines.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to Radiotherapy and Oncology

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about Radiotherapy and Oncology

Is Radiotherapy and Oncology a good journal?

By citation data, Radiotherapy and Oncology is in the lowest quartile in Radiation and 2 other subfields and ranks #791 of 897 Oncology journals by Journal Metrics Score (top 89%). A Q4 placement means its papers are cited less than most in the subfield; on its own it does not mean the journal is predatory or that its peer review is weak. Radiotherapy and Oncology's 2026 Journal Metrics Score is 0.7. Recent papers took a median of 103 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $3,210 USD. OpenAlex classifies its papers in subfields including Radiation, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine, so check that your topic fits its scope.

What is Radiotherapy and Oncology's Journal Metrics Score in 2026?

Radiotherapy and Oncology's 2026 Journal Metrics Score is 0.7, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of Radiotherapy and Oncology?

We have not found an official acceptance rate published by Radiotherapy and Oncology or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 103 days from submission to acceptance. To judge selectivity, compare Radiotherapy and Oncology's quartile and score with similar journals, or ask the editorial office.

What quartile is Radiotherapy and Oncology in?

Radiotherapy and Oncology's best quartile is Q4. By OpenAlex subfield: Q4 in Radiation; Q4 in Radiology, Nuclear Medicine and Imaging; Q4 in Pulmonary and Respiratory Medicine. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Radiotherapy and Oncology will not match this score exactly. Compare journals using one source at a time.

How long does Radiotherapy and Oncology take to accept a paper?

Radiotherapy and Oncology accepts papers a median of 103 days after submission across 100 recent PubMed records with both dates; the middle half took 70–146 days. This includes peer review, editorial handling, and revisions.

How long is the peer review time at Radiotherapy and Oncology?

PubMed records when a manuscript was received and accepted, not the individual review stages, so peer review time on its own is not available. The full time from submission to acceptance at Radiotherapy and Oncology, which includes peer review and revisions, has a median of 103 days. For the time to a first decision, check the journal's own website.

Is Radiotherapy and Oncology faster than similar journals?

Radiotherapy and Oncology's median of 103 days from submission to acceptance is faster than 68% of comparable journals with PubMed timing data.

How much does it cost to publish in Radiotherapy and Oncology?

OpenAlex lists an indicative article processing charge of $3,210 USD for Radiotherapy and Oncology. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to Radiotherapy and Oncology?

Comparable journals include Radiation Oncology, Strahlentherapie Und Onkologie, Cancer Radiotherapie, and International Journal of Radiation Oncology Biology Physics. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to Radiotherapy and Oncology?

Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 103 days from submission to acceptance in recent PubMed records.

Cite an article from this journal
Back to Search